Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 200

Similar articles for PubMed (Select 21809143)

1.

Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.

Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo BJ.

Int J Clin Pharm. 2011 Oct;33(5):806-14. doi: 10.1007/s11096-011-9541-y. Epub 2011 Aug 2.

PMID:
21809143
2.

EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.

Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U.

Hum Psychopharmacol. 2003 Dec;18(8):641-6.

PMID:
14696024
3.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
4.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
5.

Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.

Star K, Iessa N, Almandil NB, Wilton L, Curran S, Edwards IR, Wong IC.

J Child Adolesc Psychopharmacol. 2012 Dec;22(6):440-51. doi: 10.1089/cap.2011.0134. Erratum in: J Child Adolesc Psychopharmacol. 2013 Mar;23(2):142.

PMID:
23234587
6.

Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.

Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T.

J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9.

PMID:
19012820
7.

Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?

Rossom RC, Rector TS, Lederle FA, Dysken MW.

J Am Geriatr Soc. 2010 Jun;58(6):1027-34. doi: 10.1111/j.1532-5415.2010.02873.x. Epub 2010 May 7.

PMID:
20487081
8.

The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?

Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo BJ.

J Hosp Med. 2010 Apr;5(4):E8-16. doi: 10.1002/jhm.691. Review.

PMID:
20394022
10.

[Cardiovascular risk of haloperidol vs. atypical anti-psychotic drugs in schizophrenia treatment].

Dobrin I, Dobrin RP, Chele G, Stefănescu C, Knieling A, Chiriţă R.

Rev Med Chir Soc Med Nat Iasi. 2010 Jul-Sep;114(3):658-61. Romanian.

PMID:
21243790
11.

Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.

Szarfman A, Tonning JM, Levine JG, Doraiswamy PM.

Pharmacotherapy. 2006 Jun;26(6):748-58.

PMID:
16716128
12.

The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.

Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H.

J Clin Pharmacol. 2001 Dec;41(12):1310-8. Erratum in: J Clin Pharmacol 2002 May;42(5):577-9.

PMID:
11762558
13.

Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.

Bobes J, Garc A-Portilla MP, Rejas J, Hern Ndez G, Garcia-Garcia M, Rico-Villademoros F, Porras A.

J Sex Marital Ther. 2003 Mar-Apr;29(2):125-47.

PMID:
12623765
14.

Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.

Bobes J, Rejas J, Garcia-Garcia M, Rico-Villademoros F, García-Portilla MP, Fernández I, Hernández G; EIRE Study Group.

Schizophr Res. 2003 Jul 1;62(1-2):77-88.

PMID:
12765747
15.
16.

Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.

Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I; IC-SOHO Study Group.

J Clin Psychiatry. 2004 Mar;65(3):312-21.

PMID:
15096069
17.

A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.

MacDonald K, Wilson M, Minassian A, Vilke GM, Becker O, Tallian K, Cobb P, Perez R, Galangue B, Feifel D.

J Clin Psychopharmacol. 2012 Jun;32(3):317-22. doi: 10.1097/JCP.0b013e318253a2fe.

PMID:
22544013
18.
19.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
20.

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Correll CU, Leucht S, Kane JM.

Am J Psychiatry. 2004 Mar;161(3):414-25. Review.

PMID:
14992963
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk